C2C Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
C2C Wealth Management's MRK Position: Q3 2026 in Review
C2C Wealth Management reduced its Merck (MRK) stake by 1.8% in Q3 2026, selling an estimated $4.84K and leaving 1,946 shares worth $283K. The position accounts for 0.22% of the portfolio, ranked #72.
C2C Wealth Management first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.79M in Q1 2023. 1,277 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- C2C Wealth Management held 1,946 shares of Merck worth $283K as of Q3 2026.
- C2C Wealth Management sold 35 Merck shares in Q3 2026, an estimated $4.84K.
- Merck made up 0.22% of C2C Wealth Management's portfolio in Q3 2026, its #72 holding.
- C2C Wealth Management first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
- C2C Wealth Management's Merck position peaked at $1.79M in Q1 2023.
- 1,277 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on C2C Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.